PaxMedica, Inc. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PXMD research report →
About the company
PaxMedica, Inc. is a biopharmaceutical company currently in the clinical development phase, dedicated to advancing anti-purinergic drug therapies (APTs). These innovative treatments are specifically designed to address complex neurological disorders presenting with stubborn and persistent symptoms.
- CEO
- Howard J. Weisman
- IPO
- 2022
- Employees
- 6
- HQ
- Tarrytown, NY, US
Price Chart
- Market Cap
- $63.13K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.29
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -1046.98%
- ROIC
- -415.56%
- Revenue
- $0 · 0.00%
- Net Income
- $-18,290,000 · -23.56%
- EPS
- $-11.00 · 61.71%
- Op Income
- $-16,145,000
- FCF YoY
- -77.37%
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.56
- Avg Volume
- 1.85K
Get TickerSpark's AI analysis on PXMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 12, 24 | Weisman Howard J. | other | 2,927 |
| Mar 12, 24 | Sheldon Stephen | other | 3,356 |
| Mar 12, 24 | Rome Zachary | other | 4,904 |
| Mar 12, 24 | LaRochelle Karen | other | 604 |
| Mar 12, 24 | Hough David W. | other | 1,452 |
| Mar 12, 24 | Coelho John F | other | 207 |
| Mar 12, 24 | CASAMENTO CHARLES J | other | 992 |
| Feb 21, 24 | Hough David W. | other | 291 |
| Feb 21, 24 | Sheldon Stephen | other | 243 |
| Jan 29, 24 | Rome Zachary | sell | 811 |
Our PXMD coverage
Recent articles, reports, and earnings notes.
No research on PXMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PXMD report →Similar companies
Peers in the same neighborhood.